Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.
about
Preoperative endocrine therapy for older women with breast cancer: renewed interest in an old idea.pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patientsPS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancerA review of coumarin derivatives in pharmacotherapy of breast cancer.Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts.
P2860
Variation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Variation of hormonal receptor ...... amoxifen: a study of 74 cases.
@ast
Variation of hormonal receptor ...... amoxifen: a study of 74 cases.
@en
type
label
Variation of hormonal receptor ...... amoxifen: a study of 74 cases.
@ast
Variation of hormonal receptor ...... amoxifen: a study of 74 cases.
@en
prefLabel
Variation of hormonal receptor ...... amoxifen: a study of 74 cases.
@ast
Variation of hormonal receptor ...... amoxifen: a study of 74 cases.
@en
P2093
P2860
P356
P1476
Variation of hormonal receptor ...... amoxifen: a study of 74 cases.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.129
P407
P577
1996-03-01T00:00:00Z